Placing

For Immediate Release 18 July 2017

POLEMOS PLC

("Polemos" or "the Company")

Placing

Polemos, the AIM investment company, is pleased to announce a placing (the "Placing") of 2,177,777,778 Ordinary Shares of 0.01 pence each (the "Ordinary Shares") at a price of 0.0225 pence per Ordinary Share together with a proposed Director's subscription of 44,444,444 Ordinary Shares to raise in aggregate gross proceeds of £500,000. The Placing has been undertaken with certain private investors. The completion of the Placing and proposed Director's Subscription is conditional, inter alia, upon admission of the Placing Shares to trading on AIM. The proceeds of the Placing will be used for working capital and to assist in seeking investment opportunities in line with the Company's investing policy.

Details of the Placing and proposed Director's Subscription

The Company advises that one director of the Company, namely Hamish Harris, intends to subscribe for a total of 44,444,444 Ordinary Shares on the same terms (the "Director's Shares") for a sum of £10,000 following the announcement of the Placing.

Application is being made for the Placing Shares and Director's Shares, to be admitted to trading on AIM ("Admission"), such Admission is expected to occur on or around 24 July 2017.

On Admission the Placing Shares and Director's Shares will rank pari passu in all respects with the existing ordinary shares of the Company, including the right to receive all dividends and other distributions declared after the date of their issue. 

Following Admission of the Placing Shares and Director's Shares, the Company will then have 5,160,915,400 Ordinary Shares in issue with voting rights and admitted to trading on AIM. This figure may then be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

END.

For further information, please contact: